84 related articles for article (PubMed ID: 24916398)
41. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
[TBL] [Abstract][Full Text] [Related]
42. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
[TBL] [Abstract][Full Text] [Related]
43. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
Takeda T; Tsubaki M; Matsuda T; Kimura A; Jinushi M; Obana T; Takegami M; Nishida S
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445730
[TBL] [Abstract][Full Text] [Related]
44. Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells.
Ward ST; Dangi-Garimella S; Shields MA; Collander BA; Siddiqui MA; Krantz SB; Munshi HG
J Cell Biochem; 2011 Oct; 112(10):2966-73. PubMed ID: 21678462
[TBL] [Abstract][Full Text] [Related]
45. Clonal selection in tamoxifen resistance.
Jin K; Sukumar S
Cancer Biol Ther; 2010 May; 9(9):725-7. PubMed ID: 20421729
[No Abstract] [Full Text] [Related]
46.
Simons M; Gulcher JR; Chittenden TW
Aging (Albany NY); 2020 Jun; 12(11):10001-10003. PubMed ID: 32530820
[No Abstract] [Full Text] [Related]
47. pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner.
Mandal R; Raab M; Matthess Y; Becker S; Knecht R; Strebhardt K
Mol Oncol; 2014 Mar; 8(2):232-49. PubMed ID: 24342355
[TBL] [Abstract][Full Text] [Related]
48. [Transcription factor snail and epithelial-mesenchymal transition of tumor].
Li L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):749-52. PubMed ID: 21924044
[No Abstract] [Full Text] [Related]
49. ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition.
Shin S; Blenis J
Cell Cycle; 2010 Jul; 9(13):2483-4. PubMed ID: 20543576
[No Abstract] [Full Text] [Related]
50. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2.
Smith BN; Burton LJ; Henderson V; Randle DD; Morton DJ; Smith BA; Taliaferro-Smith L; Nagappan P; Yates C; Zayzafoon M; Chung LW; Odero-Marah VA
PLoS One; 2014; 9(8):e104987. PubMed ID: 25122124
[TBL] [Abstract][Full Text] [Related]
51. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract][Full Text] [Related]
52. Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells.
To NB; Truong VN; Ediriweera MK; Cho SK
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232636
[TBL] [Abstract][Full Text] [Related]
53. Revisiting Epithelial Carcinogenesis.
Méndez-López LF
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806442
[TBL] [Abstract][Full Text] [Related]
54. Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer.
Ruscitto F; Roda N; Priami C; Migliaccio E; Pelicci PG
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682953
[TBL] [Abstract][Full Text] [Related]
55. A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.
Sahoo S; Mishra A; Kaur H; Hari K; Muralidharan S; Mandal S; Jolly MK
NAR Cancer; 2021 Sep; 3(3):zcab027. PubMed ID: 34316714
[TBL] [Abstract][Full Text] [Related]
56. Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.
Kielbik M; Szulc-Kielbik I; Klink M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478150
[TBL] [Abstract][Full Text] [Related]
57. CBP-mediated Slug acetylation stabilizes Slug and promotes EMT and migration of breast cancer cells.
Dai X; Xin Y; Xu W; Tian X; Wei X; Zhang H
Sci China Life Sci; 2021 Apr; 64(4):563-574. PubMed ID: 32737855
[TBL] [Abstract][Full Text] [Related]
58. Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells.
Chang YC; Cheung CHA; Kuo YL
Front Cell Dev Biol; 2020; 8():485. PubMed ID: 32695778
[TBL] [Abstract][Full Text] [Related]
59. Regulation of breast cancer metastasis signaling by miRNAs.
Petri BJ; Klinge CM
Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859
[TBL] [Abstract][Full Text] [Related]
60. IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation.
Zheng Y; Sowers JY; Houston KD
Front Endocrinol (Lausanne); 2020; 11():233. PubMed ID: 32435229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
